FDA authorizes Novavax COVID-19 vaccine for first booster dose ...Middle East

Novavax on Wednesday received Food and Drug Administration authorization for a booster dose of its COVID-19 vaccine. Yet unlike the bivalent mRNA vaccines currently on the market, Novavax's booster only targets the original strain of the virus, rather than the original strain and the omicron BA.4/BA.5 subvariants. The company is studying an omicron-specific vaccine, but executives have said they think the current vaccine provides durable protection across different variants of the virus. Last week, the company said its clinical trial showed a single booster dose given 8 to 11 months after a Novavax primary series resulted in increased antibodies against omicron BA.1, BA.2 and the

Hence then, the article about fda authorizes novavax covid 19 vaccine for first booster dose was published today ( Wednesday 19/10/2022 - 08:20 PM ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA authorizes Novavax COVID-19 vaccine for first booster dose )

Also on site :

• Meet the ex-Google CMO who quit with a seven-figure package by 28—he says getting promoted was easy because he just ‘disregarded all the rules’
• Marco Bezzecchi wins USA MotoGP to extend perfect start to season
• Sivers Semiconductors Announces Availability of Daybreak™ 5G/6G Advanced ICs For Emerging FR3 Applications